Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 percent of all prescriptions filled in the United States yet accounted ...
Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...
According to the American Medical Association, health related costs have been on the rise in recent years. Overall, health-related spending in the U.S. increased by over 7% between 2022 and 2023, a ...
As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation, is ...
This September marks 40 years since the birth of the generic drug industry in the United States. Nine out of every 10 prescriptions in the U.S. are filled by a generic drug. Generics — effectively ...
WASHINGTON, DC - APRIL 2: President Donald Trump signs an executive order imposing tariffs on imported goods during a "Make America Wealthy Again" trade announcement event in the Rose Garden at the ...
Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...
The Centers for Medicare & Medicaid Services just announced the next 15 brand-name medicines selected for Medicare’s drug price negotiation program, which mandates price reductions of at least 25%.
Policy interventions, including large-scale private-public partnerships, are key to reducing prescription drug shortages and averting patient harm. Shortages of prescription generic drugs, which ...
Cancer drugs among nearly 400 medicines at risk of shortage in UK - Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable ...
Dear reader, between protecting innovation and encouraging generic medicines, the Saudi Food and Drug Authority (SFDA) has to ...